Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04462471
Title Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester (Limited protocol activities) Harrison New York 10604 United States Details
Memorial Sloan-Kettering Cancer Center (All protocol activities) New York New York 10065 United States Details
Memorial Sloan Kettering Nassau (Limited protocol activities) Rockville Centre New York 11553 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field